A comparative evaluation of analgesic and anti-inflammatory activities of two medicinal plants rubia cordifolia and cassia fistula in wistar albino rats
DOI:
https://doi.org/10.18203/2319-2003.ijbcp20170939Keywords:
Anti-inflammatory, Analgesics, Adverse effects, Cassia fistula (CF) leaves, Diclofenac, Rubia cordifolia (RC) rootsAbstract
Background: Pain and inflammation are disabling accompaniments of many medical conditions. So, controlling both pain and inflammation assumes the top priority for the physician. Inflammation is a part of a complex biological response of vascular tissues to harmful stimuli such as pathogens, chemicals or irritants. Therapy of pain and inflammation has always been debatable.
Methods: Rats were divided into 8 groups of 6 animals of each. The anti-inflammatory activity was studied with carrageenan induced rat paw edema and cotton pellet induced granuloma models. The analgesic activity was evaluated using Eddy’s hot plate model. The aqueous extract of Rubia cardifolia root and Cassia fistula leaf preparations were compared with Diclofenac in both acute and sub acute inflammatory models and also in pain model.
Results: Various test result parameters were statistically analysed at P value <0.5. In Eddy's hot plate model both RC and CF preparations prolonged the response reaction time, while CF preparation showed longer reaction time than that of RC preparation. In carrageenan induced paw edema and cotton pellet induced granuloma models, both RC and CF preparations showed significant decrease in paw edema volume and granuloma dry weight respectively, but less than that of Diclofenac. RC preparation found to have dose dependant in inflammatory models.
Conclusions: RC root and CF leaf preparations were compared head to head and they have been found to have significant dose dependant analgesic activity and dose independent acute and sub acute anti inflammatory activities. Though CF leaf preparation appeared to be a good analgesic than RF root preparation, but failed to do so as an anti inflammatory agent in both inflammatory models. But both test preparations were not equivalent to Diclofenac in all three models.
Metrics
References
Rang HP, Dale MN, Ritter JM, Henderson G. Analgesic Drugs. In: Rang and Dale’s Pharmacology. 7th ed. Edinburgh: Elsevier Churchill Livingstone; 2012:503-524.
Cole BE. Pain Management: Classifying, Understanding and Treating Pain. Hospital Physician; 2002:23-30.
Ferrero-Miliani L, Nielsen OH, Anderson PS, Girardin SE. Chronic inflammation: importance of NOD2 and NALP3 in interleukin-1beta generation. Clin. Exp. Immunol. 2007;147(2):227-35.
Anderson WAD. Inflammation and Healing. Pathology, 9th Edition, C.V. Mosby co. 1990;1:67.
Walker SM. Introduction of pain. In: Macintyre PE, Walker SM, Rawbotham DJ, editors. Clinical pain Management: Acute pain. 2nd Ed. Hodder & Stoughton: London; 2008:20-31.
Rang HP, Dale MM, Ritter JM, Henderson G. Anti-inflammatory and immunosuppressant drugs. In: Rang and Dale’s Pharmacology, 7th edition. Edinburgh: Elseveir Churchill Livingstone; 2008:318-34.
Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D. Survey of chronic pain in Europe; Prevalence, impact on daily life and treatment. Eur J Pain. 2006;10:287-333.
Wane JR, Bakhle YS, Botting RN. Cyclooxygenases 1 and 2. Annual Review of pharmacology and toxicology. 2015;38:97-120.
CKS, Lirk P, Tan CH, Seymour RA. Evidence- Based Update on Nonsteroidal Anti-Inflammatory Drugs. Clin Med Res. 2007;5(1):19-34.
World Health Organization. WHO’s Pain ladder. Geneva, Switz: World Health Organization; 2010. Available from: www.who.int/cancer/palliative/painladder/en/.Accessed 2015 july 25.
Watanabe S, Bruera E. Corticosteroids as adjuvant analgesics. J Pain Symptom Manage. 1991;9(7):442-5.
Sengupta R, Sheorey SD, Hinge MA. Analgesic and Anti-inflammatory Plants: An Updated Review. International Journal of pharmaceutical sciences Review and Research. 2012;12(2):114-19.
Kasture SB, Kasture VS, Chopde CT. Anti-inflammatory activity of Rubia Cordifolia roots. Journal of Natural Remedies. 2001;(1/2):111-15.
Joharapurkar AA, Deode NM, Zambad SP, Umathe SN. Immunomodulatory Activity Of Alcoholic Extract Of Rubia Cordifolia Linn. Indian Drugs. 2003;40(3):179-81.
Neelam C, Ranjan B, Komal S, Nootan C. Review on cassia fistula. Int J Res Ayur Pharmacy. 2011;2(2):426-30.
Mohan H. In: Harsh Mohan's text book of pathology. 6th edition. New Delhi: JAYPEE Brothers Medical Publishers private limited; 2010.
Suresha RN, Amoghimath S, Vaibhavi PS, Shruthi SL, Jayanthi MK, Kalabharathi HL. Evaluation of analgesic activity of perindopril in albino mice. J Adv Pharm Technol Res. 2014;5(3):129-33.
Radwan MAA, Ragab EA, Sabry NM, El-Shenawy SM. Synthesis and biological evaluation of new 3-substituted indole derivatives as potential anti-inflammatory and analgesic agents. Bioorg Med Chem. 2007;15:3832-41.
Parmar N, Rawat M, Kumar T. Evaluation of anti-inflammatory potential of Kigelia pinnata leaf extract in wistar rats. Asia N J Pharm Clin Res. 2012;5(1):95-7.
Winter CA, Porter CC. Effect of alterations in the side chain upon anti-inflammatory and liver glycogen activities of hydrocortisone esters. J Am Pharm Assoc Sci Educ. 1957;46:515-19.
Spector WG. The Granulomatous Inflammatory Exudate. Int Rev Exp Pathol. 1969;8:51-5.
